Results 1 to 10 of about 62,082 (217)

Agreement between seroprevalence- and model-based estimates of COVID-19 burden [PDF]

open access: yesGlobal Health Action
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic caused significant global harm. Seroprevalence studies detected antibody increases from SARS-CoV-2 infection, assessing transmission and risk from infection.
Nana Owusu-Boaitey   +6 more
doaj   +2 more sources

Hepatitis E Seroprevalence in Europe: A Meta-Analysis

open access: yesViruses, 2016
There have been large numbers of studies on anti-HEV IgG seroprevalence in Europe, however, the results of these studies have produced high variability of seroprevalence rates, making interpretation increasingly problematic.
Eik Vettorazzi   +2 more
exaly   +3 more sources

Seroprevalence of Q fever among humans and animals in East Africa: a systematic review and meta-analysis [PDF]

open access: yesOne Health Outlook
Q fever is a neglected zoonotic disease caused by Coxiella burnetii with a global distribution. It has a significant public health implication in resource-limited settings.
Simegnew Adugna Kallu   +6 more
doaj   +2 more sources

SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021

open access: yesBMJ Global Health, 2022
Introduction Estimating COVID-19 cumulative incidence in Africa remains problematic due to challenges in contact tracing, routine surveillance systems and laboratory testing capacities and strategies.
  +90 more
doaj   +1 more source

Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia

open access: yesInternational Journal of Infectious Diseases, 2021
Background: Serologic testing provides better understanding of SARS-CoV-2 prevalence and its transmission. This study was an investigation of the prevalence of antibodies to SARS-CoV-2 among blood donors in Saudi Arabia.
Ayman Banjar   +21 more
doaj   +1 more source

Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022

open access: yesEmerging Infectious Diseases, 2023
We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020–December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%–46.5%).
Rebecca A. Falender   +4 more
doaj   +1 more source

Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children

open access: yesSwiss Medical Weekly, 2023
BACKGROUND: Much remains unknown regarding the evolution of SARS-CoV-2 seroprevalence and variability in seropositive children in districts, schools and classes as only a few school-based cohort studies exist.
Sarah R. Haile   +6 more
doaj   +1 more source

Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria

open access: yesParasite Epidemiology and Control, 2021
Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals.
Falmata Kyari, PhD   +4 more
doaj   +1 more source

Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown

open access: yesBMC Infectious Diseases, 2022
Highlights 1. Two months after the COVID-19 outbreak in Wuhan, the seroprevalence for IgM and IgG in the convalescent patients was 31.82% and 77.27%, respectively.
Yueting Tang   +10 more
doaj   +1 more source

Spanish HCMV Seroprevalence in the 21st Century

open access: yesViruses, 2023
Human cytomegalovirus (HCMV) is linked to age-related diseases like cardiovascular disease, neurodegenerative conditions, and cancer. It can also cause congenital defects and severe illness in immunocompromised individuals.
Pablo Álvarez-Heredia   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy